Integrative Pan-Cancer Analysis Confirmed that FCGR3A is a Candidate Biomarker Associated With Tumor Immunity

por Li, Lilin, Huang, Zijian, Du, Kunpeng, Liu, Xiang, Li, Chunhui, Wang, Duanyu, Zhang, Yangfeng, Wang, Changqian, Li, Jiqiang
Publicado 2022

MYLK4 promotes tumor progression through the activation of epidermal growth factor receptor signaling in osteosarcoma

por Yang, Mengkai, Zhang, Tao, Zhang, Yangfeng, Ma, Xiaojun, Han, Jing, Zeng, Ke, Jiang, Yafei, Wang, Zongyi, Wang, Zhuoying, Xu, Jing, Hua, Yingqi, Cai, Zhengdong, Sun, Wei
Publicado 2021

Inhibition of sphingolipid metabolism in osteosarcoma protects against CD151-mediated tumorigenicity

por Wang, Hongsheng, Jin, Xinmeng, Zhang, Yangfeng, Wang, Zhuoying, Zhang, Tao, Xu, Jing, Shen, Jiakang, Zan, Pengfei, Sun, Mengxiong, Wang, Chongren, Hua, Yingqi, Ma, Xiaojun, Sun, Wei
Publicado 2022